Latest Biotech News

Merck entered a new AI-enabled biologics discovery collaboration with Protillion Biosciences, expanding use of Protillion’s “lab-in-the-loop” on-chip antibody platform. Under the multi-target...

Jazz Pharmaceuticals and AbCellera announced a preclinical research collaboration to discover next-generation T-cell engaging (TCE) multispecific antibodies aimed at GI cancers and other solid...

Demand for Novo Nordisk’s Wegovy pill surged immediately after UK approval, with a major online pharmacy reporting a waiting list of about 30,000 people per week. The report highlights how access...

Hackers claimed they stole Novo Nordisk AI models and manufacturing recipes, escalating cyber risk around drug development and production know-how. The group’s claim describes attempted extortion...

10x Genomics and Cleveland Clinic began a multiyear collaboration to identify spatial biomarkers predicting response to antibody-drug conjugates in advanced bladder cancer. The work will analyze...

At the 2026 ASCO Annual Meeting, results from ROSETTA Lung-02 showed that pumitamig (BNT327/BMS986545) plus chemotherapy produced high response rates in first-line NSCLC across histologies and...

Germany backed away from a variable discount pricing plan for branded drugs after industry pushback, Reuters reported—switching instead to a fixed approach. The original proposal was designed to...

NorthX Biologics and enGenes Biotech launched an integrated collaboration to build an E. coli-based protein production platform covering strain design through GMP manufacturing. The companies...

CGT Catapult unveiled a continuous bioprocessing platform for advanced therapy medicinal products (ATMPs), aiming to raise yields and productivity to expand gene therapy manufacturing...

FDA has reversed course on uniQure’s Huntington’s disease gene therapy, clearing the way for the company to file for US accelerated approval. After a dispute that included scrutiny of the...

Moderna’s seasonal mRNA flu vaccine mRNA-1010 (mFLUSIVA) is under renewed FDA examination ahead of an upcoming Vaccines and Related Biological Products Advisory Committee meeting. FDA previously...

Bristol Myers Squibb’s pumitamig (BNT327/BMS986545) combined with chemotherapy generated high response rates in a first-line phase 2 readout from the ROSETTA Lung-02 study. Results presented at...

Researchers at the University of Cologne’s Center for Molecular Medicine Cologne (CMMC) report that KRAS-driven pancreatic tumors become dependent on caspase-8 and can be pushed into necroptosis...

Merck & Co. launched a multi-target AI drug discovery collaboration with Protillion Biosciences using Protillion’s “lab-in-the-loop” antibody discovery and on-chip protein display platform. The...

Beren Therapeutics raised $300 million as it moves adrabetadex toward FDA review under priority review. The company’s funding arrives at a critical point for adrabetadex, its drug intended for...

Germany has backed away from a plan to implement variable discount pricing on branded drugs after industry pushback, Reuters reports. The earlier proposal was part of healthcare reform efforts...

Sophia Genetics priced a $50 million underwritten public offering of ordinary shares, selling more than 10 million shares at $4.75 each. The offering is expected to close shortly, and the company...

Jazz Pharmaceuticals and AbCellera announced a preclinical collaboration to discover and develop next-generation T-cell engaging multispecific antibodies for GI cancers and other solid tumors. The...

Eli Lilly agreed to acquire 4E Therapeutics, a startup developing non-opioid pain programs built around MNK inhibitors and the MNK-eIF4E signaling axis. Lilly said the deal expands its early...

Merck & Co. is expanding AI-powered biologics discovery through a multi-target collaboration and license with Protillion Biosciences, a move that could generate up to $510 million in milestone...